- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Lava Therapeutics flows toward public markets
Biox Biosciences, Novo, Sanofi and Merck & Co are all in line to exit the immuno-oncology therapy developer, which has filed for a $100m initial public offering.
Mar 5, 2021Caribou clinches $115m series C
UC Berkeley-founded genome editing technology developer Caribou Biosciences has completed its first funding round in five years.
Mar 5, 2021Exscientia expands series C to $100m
BlackRock has joined the University of Dundee spinout’s series C round, following a $60m first close in May last year.
Mar 5, 2021Uplight upgrades to unicorn valuation
The utility engagement software provider secured the funding in a round co-led by Schneider Electric and AES Corporation at a $1.5bn valuation.
Mar 5, 2021Corporates help Infcurion find $22m
Ceres, Dai Nippon Printing, Japan Post Investment, Money Forward, TIS and Toppan all backed the business development, incubation and investment company's latest round.
Mar 5, 2021Yugabyte records $48m round
The database platform developer will embark on international expansion with funding raised from investors including Dell Technologies Capital and Wipro Ventures.
Mar 4, 2021Asuragen awaits results of $320m Bio-Techne acquisition
Merck & Co is set to exit the genomic services and cancer diagnostics provider in an acquisition by Bio-Techne potentially sized at $320m.
Mar 4, 2021TaxBit takes $100m in series A round
PayPal Ventures and Coinbase Ventures are among the new investors in TaxBit, the creator of a cryptocurrency tax automation software platform.
Mar 4, 2021Anghami tunes into $220m reverse merger
Du, MBC and Mobily are set to exit the music streaming platform operator as it agrees to list through a reverse takeover.
Mar 4, 2021MoneyLion devours WTI in acquisition deal
The financial planning technology developer has been bought by MoneyLion just over a year after raising money from NFP Global.
Mar 4, 2021Telus pops into PocketPills' series B
Telus’ corporate venturing unit has led a $23.7m round for the Canadian online pharmacy as it seeks to take its coverage nationwide.
Mar 4, 2021Sage muses on Countingup's series A round
Sage participated in a $12.6m round for the business banking and accounting software provider that took its total funding above $21m.
Mar 4, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
